Sort
23,748 grants matching “melanoma”
Clefts/Craniofacial Anomalies and Cancer Susceptibility
$248,839Renato Menezes Silva · University Of Pittsburgh At Pittsburgh · R00 · FY2010 · DE
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
$248,813Joseph Markowitz · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2021 · CA
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
$248,813Joseph Markowitz · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2022 · CA
Identifying Events and Genetic Regulators of Melanoma Progression
$248,811Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R00 · FY2010 · AR
B-RAF Regulation of the Cell Cycle in Melanoma
$248,776Andrew E Aplin · Thomas Jefferson University · R01 · FY2012 · CA
B-RAF Regulation of the Cell Cycle in Melanoma
$248,776Andrew E Aplin · Thomas Jefferson University · R01 · FY2011 · CA
Building an in-vivo gene regulatory network for melanocyte stem cell maintenance.
$248,756Melissa L Harris · University Of Alabama At Birmingham · R00 · FY2018 · AG
Generation and Repair of an Unusual UV Photoproduct
$248,715Joan B. Broderick · Montana State University - Bozeman · R01 · FY2006 · GM
Skin Tissue Engineering
$248,714Bethany E Perez White · Northwestern University At Chicago · P30 · FY2017 · AR
PAK Kinases Regulate Melanoma Chemoresistance and Metastasis
$248,709Anand K Ganesan · University Of California-Irvine · R01 · FY2014 · CA
Building an in-vivo gene regulatory network for melanocyte stem cell maintenance.
$248,688Melissa L Harris · University Of Alabama At Birmingham · R00 · FY2016 · AG
T CELL RESPONSE TO GENETICALLY ENGINEERED AND MATURED DC
$248,681University Of Connecticut Sch Of Med/Dnt · R01 · FY2003 · CA
T cell response in Aggregatibacter actinomycetemcomitans-associated periodontal disease
$248,627Drake Winslow Williams · University Of Minnesota · R00 · FY2025 · DE
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$248,608Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Reviving cancer immune surveillance with CD4 T cell help
$248,602Michael Clavon Brown · Duke University · R00 · FY2022 · CA
Informatics, Tissue Resource, and Pathology Core
$248,519Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Omega-6/Omega-3 Fatty Acid Ratio and Tumorigenesis
$248,500Jing X Kang · Massachusetts General Hospital · R01 · FY2006 · CA
DC VACCINE TO ELICIT POLYSPECIFIC THI ANTI-TUMOR IMMUNIT
$248,486Louis D Falo · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · CA
Development of Virtual Tumor
$248,450Thomas S Deisboeck · Massachusetts General Hospital · U56 · FY2009 · CA
Project 1: Personalized Adjuvant Immunotherapy for High-risk Colorectal Cancer.
$248,431Michael J Overman · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Targeting the ERK Pathway in KRAS-and BRAF-Driven Lung Cancers
$248,430Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Targeting the ERK Pathway in KRAS-and BRAF-Driven Lung Cancers
$248,430Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$248,429Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
WNT AND FRIZZLED SIGNALING IN MAMMARY ONCOGENESIS
$248,428Columbia University Health Sciences · R01 · FY2000 · CA
Innate Immune Sensing of Rift Valley Fever Virus
$248,423Amy G Hise · Case Western Reserve University · R21 · FY2009 · AI